These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 18305428)

  • 1. Structure and catalytic properties of carboxylesterase isozymes involved in metabolic activation of prodrugs.
    Hosokawa M
    Molecules; 2008 Feb; 13(2):412-31. PubMed ID: 18305428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of intestinal carboxylesterase in the oral absorption of prodrugs.
    Imai T; Ohura K
    Curr Drug Metab; 2010 Nov; 11(9):793-805. PubMed ID: 21189138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hydrolysis by carboxylesterase and disposition of prodrug with ester moiety].
    Imai T
    Yakugaku Zasshi; 2007 Apr; 127(4):611-9. PubMed ID: 17409690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human carboxylesterase isozymes: catalytic properties and rational drug design.
    Imai T
    Drug Metab Pharmacokinet; 2006 Jun; 21(3):173-85. PubMed ID: 16858120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genomic structure and transcriptional regulation of the rat, mouse, and human carboxylesterase genes.
    Hosokawa M; Furihata T; Yaginuma Y; Yamamoto N; Koyano N; Fujii A; Nagahara Y; Satoh T; Chiba K
    Drug Metab Rev; 2007; 39(1):1-15. PubMed ID: 17364878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human carboxylesterases: an update on CES1, CES2 and CES3.
    Sanghani SP; Sanghani PC; Schiel MA; Bosron WF
    Protein Pept Lett; 2009; 16(10):1207-14. PubMed ID: 19508181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of carboxylesterases expressed in rat intestine and effects of their hydrolyzing activity in predicting first-pass metabolism of ester prodrugs.
    Liu D; Gao J; Zhang C; Ren X; Liu Y; Xu Y
    Pharmazie; 2011 Nov; 66(11):888-93. PubMed ID: 22204136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biotransformation Capacity of Carboxylesterase in Skin and Keratinocytes for the Penta-Ethyl Ester Prodrug of DTPA.
    Fu J; Sadgrove M; Marson L; Jay M
    Drug Metab Dispos; 2016 Aug; 44(8):1313-8. PubMed ID: 27130352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of recombinant human carboxylesterases: fluorescein diacetate as a probe substrate for human carboxylesterase 2.
    Wang J; Williams ET; Bourgea J; Wong YN; Patten CJ
    Drug Metab Dispos; 2011 Aug; 39(8):1329-33. PubMed ID: 21540359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Presence and inter-individual variability of carboxylesterases (CES1 and CES2) in human lung.
    Gabriele M; Puccini P; Lucchi M; Vizziello A; Gervasi PG; Longo V
    Biochem Pharmacol; 2018 Apr; 150():64-71. PubMed ID: 29407485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opossum carboxylesterases: sequences, phylogeny and evidence for CES gene duplication events predating the marsupial-eutherian common ancestor.
    Holmes RS; Chan J; Cox LA; Murphy WJ; VandeBerg JL
    BMC Evol Biol; 2008 Feb; 8():54. PubMed ID: 18289373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of substrate specificity among human arylacetamide deacetylase and carboxylesterases.
    Fukami T; Kariya M; Kurokawa T; Iida A; Nakajima M
    Eur J Pharm Sci; 2015 Oct; 78():47-53. PubMed ID: 26164127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hydrolysis of irinotecan and its oxidative metabolites, 7-ethyl-10-[4-N-(5-aminopentanoic acid)-1-piperidino] carbonyloxycamptothecin and 7-ethyl-10-[4-(1-piperidino)-1-amino]-carbonyloxycamptothecin, by human carboxylesterases CES1A1, CES2, and a newly expressed carboxylesterase isoenzyme, CES3.
    Sanghani SP; Quinney SK; Fredenburg TB; Davis WI; Murry DJ; Bosron WF
    Drug Metab Dispos; 2004 May; 32(5):505-11. PubMed ID: 15100172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of carboxylesterases and its impact on pharmacokinetics and pharmacodynamics: an up-to-date review.
    Liu Y; Li J; Zhu HJ
    Expert Opin Drug Metab Toxicol; 2024 May; 20(5):377-397. PubMed ID: 38706437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Difference in substrate specificity of carboxylesterase and arylacetamide deacetylase between dogs and humans.
    Yoshida T; Fukami T; Kurokawa T; Gotoh S; Oda A; Nakajima M
    Eur J Pharm Sci; 2018 Jan; 111():167-176. PubMed ID: 28966098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carboxylesterase-2 is a highly sensitive target of the antiobesity agent orlistat with profound implications in the activation of anticancer prodrugs.
    Xiao D; Shi D; Yang D; Barthel B; Koch TH; Yan B
    Biochem Pharmacol; 2013 Feb; 85(3):439-47. PubMed ID: 23228697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mammalian carboxylesterase 3: comparative genomics and proteomics.
    Holmes RS; Cox LA; VandeBerg JL
    Genetica; 2010 Jul; 138(7):695-708. PubMed ID: 20422440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct patterns of aging effects on the expression and activity of carboxylesterases in rat liver and intestine.
    Ohura K; Tasaka K; Hashimoto M; Imai T
    Drug Metab Dispos; 2014 Feb; 42(2):264-73. PubMed ID: 24271336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carboxylesterase Activities and Protein Expression in Rabbit and Pig Ocular Tissues.
    Hammid A; Fallon JK; Lassila T; Salluce G; Smith PC; Tolonen A; Sauer A; Urtti A; Honkakoski P
    Mol Pharm; 2021 Mar; 18(3):1305-1316. PubMed ID: 33595329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nucleoside ester prodrug substrate specificity of liver carboxylesterase.
    Landowski CP; Lorenzi PL; Song X; Amidon GL
    J Pharmacol Exp Ther; 2006 Feb; 316(2):572-80. PubMed ID: 16223870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.